Author:
Harrop Richard,Drury Noel,Shingler William,Chikoti Priscilla,Redchenko Irina,Carroll Miles W.,Kingsman Susan M.,Naylor Stuart,Griffiths Richard,Steven Neil,Hawkins Robert E.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy
Reference22 articles.
1. Braybrooke JP, Slade A, Deplanque G et al (2005) Phase I study of MetXia-P450 gene therapy and oral cyclophosphamide for patients with advanced breast cancer or melanoma. Clin Cancer Res 11:1512
2. Eder JP, Kantoff PW, Roper K et al (2000) A phase I trial of a recombinant vaccinia virus expressing prostate-specific antigen in advanced prostate cancer. Clin Cancer Res 6:1632
3. Ghiringhelli F, Larmonier N, Schmitt E et al (2004) CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative. Eur J Immunol 34:336
4. Griffiths RW, Gilham DE, Dangoor A et al (2005) Expression of the 5T4 oncofoetal antigen in renal cell carcinoma: a potential target for T-cell-based immunotherapy. Br J Cancer 93:670
5. Harrop R, John J, Carroll MW (2006) Recombinant viral vectors: cancer vaccines. Adv Drug Deliv Rev 58:931
Cited by
75 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献